Regenerative methods in osteoarthritis

Area of Science:

• Orthopedics and Regenerative Medicine
• Biomaterials Science
• Cell Biology

Background:

• Osteoarthritis (OA) is a prevalent degenerative joint disease with limited effective treatment options.
• Current OA management primarily focuses on symptom relief rather than disease modification or tissue repair.
• Tissue engineering and regenerative medicine offer potential for cartilage repair in OA.

Purpose of the Study:

• To provide an overview of mesenchymal stem cells (MSCs) and platelet-rich plasma (PRP) applications in osteoarthritis.
• To discuss the potential of regenerative therapies for cartilage repair in OA.
• To highlight the need for further research and standardization of MSC and PRP therapies for OA.

Main Methods:

• Review of current literature on MSC and PRP applications in osteoarthritis.
• Analysis of the role of biomaterials, cells, and bioactive molecules in regenerative strategies.
• Synthesis of evidence regarding the efficacy of regenerative therapies for OA.

Main Results:

• Mesenchymal stem cells (MSCs) and platelet-rich plasma (PRP) are leading regenerative therapies for OA.
• These therapies aim to protect, restore, or enhance the function of damaged joint tissues.
• Conflicting evidence exists regarding the efficacy of regenerative therapies, necessitating more research.

Conclusions:

• Regenerative strategies using MSCs and PRP present a promising avenue for osteoarthritis treatment.
• Standardization and further investigation are crucial to establish the definitive efficacy of these therapies.
• Optimizing MSC and PRP applications could significantly improve outcomes for osteoarthritis patients.